XRHealth
The announcement comes just three months after XRHealth announced it acquired cognitive training VR platform NeuroReality and its assets.
The aim is to allow clinicians to transition between several therapeutic environments to optimize treatment outcomes.
The acquisition includes all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.
The funding marks the completion of the company's merger with Amelia Virtual Care, and the investment will be used to support the combined companies' growth.
Digital health leaders say frameworks already exist that can be adopted for AI regulation, but going too far with rules could stifle innovation.
From the end of the Public Health Emergency to the launch of ChatGPT and the Apple Vision Pro, executives reflect on what stood out to them this year.
Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.
XRHealth, HTC Vive and Nord-Space Aps engineered the Vive Focus 3 headset to withstand microgravity conditions to help treat astronauts' mental health in space.
The company provided hundreds of virtual reality headsets to 30 healthcare centers across Israel to help patients struggling with PTSD, anxiety and stress.
The company will first use the patent to combine the Apple Watch with Apple's new augmented reality headset Apple Vision Pro for closed loop AI-enabled treatment.